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INTRODUCTION
The global increased prevalence of allergy is such thatbetween 20–30% of the world’s population now suffers
from some form of allergic disease, with considerable and
continuing increases in prevalence over the last three de-
cades.1 Although the specialty of allergy is practiced and
recognized in most developed countries, even some devel-
oped countries lack adequate resources to manage the local
burden of allergic disease. In many developing countries
there are few or no allergy specialists due to either the
prevailing healthcare infrastructure, to socio-economic rea-
sons, and/or to the lack of recognition of allergy as a clinical
specialty. There is often minimal or no inclusion of allergy
education/training in the undergraduate medical curriculum,
and this shortfall must be addressed if the increasing burden
of allergic diseases is to be managed.
The majority of patients with common allergic diseases
around the world are treated by primary care physicians, and
not by trained specialists. However, a lack of appropriate
education and training in allergy at the undergraduate level
leaves many medical graduates with low baseline knowledge
and skills in the science and practice of allergy. In addition,
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because it is a relatively new discipline, education and train-
ing in allergy in medical schools has lagged behind scientific
and clinical developments in this field, and there are few
allergy specialists available to teach this multidisciplinary
subject. This phenomenon is described by the World Health
Organization as the knowledge/practice gap. Unless allergy
training is included as an essential part of undergraduate
medical education at the clinical level, many physicians will
qualify with inadequate competency to manage the diagnosis
and treatment of allergic diseases at the primary care level.
Thus, a cycle of lack of basic knowledge about the most
common allergic diseases, lack of recognition of allergic
disease at the clinical level, and inadequate knowledge and
skills in the diagnosis and treatment of allergic diseases will
be perpetuated.
To help break this cycle the World Allergy Organiza-
tion (WAO) presents broad guidelines for the curriculum of
education and training of medical students in the immune
mechanisms of allergic responses, and the commonest man-
ifestations of clinical allergy. Inclusion of these educational
guidelines into curriculum development will provide medical
graduates with the basic knowledge required to recognize and
treat common allergic diseases during postgraduate training
or as a general practitioner (care level 1), and the knowledge
of when to refer the more complex problems to appropriate
organ-based or allergy specialists (care levels 2 and 3).2
These guidelines outline optimal curriculum content, and are
offered for consideration and modification to meet local
needs and healthcare provision structures. Although certain
immunodeficiency states may accompany allergies or may
need to be considered in the differential diagnosis of allergic
diseases, this document is not intended to provide a compre-
hensive guideline on the teaching of immune deficiencies to
medical students.
BROAD OBJECTIVES OF THE WAO GUIDELINES
FOR MEDICAL STUDENT TRAINING IN
ALLERGY
The objectives are concordant with the recommenda-
tions made by the WAO in the 2008 WAO Position Statement
“Requirements for Physician training in Allergy: Key clinical
competencies appropriate for the care of patients with allergic
or immunologic diseases”2 and align with competency at the
first level of care. This represents only the first step underly-
ing any training program for physicians who will be seeing
patients with allergy.
LEVELS OF COMPETENCE
Levels of competence required for medical school grad-
uates are divided into 2 main categories as follows:
I. Threshold Knowledge
a. An in-depth understanding
b. Familiar with principles
c. Aware of principles
II. Practical Skills
a. Competent to perform and fully understand the scien-
tific basis and clinical value
b. Witnessed its use in practice and full understanding of
scientific basis and clinical value
c. Familiar with principles and scientific basis
KNOWLEDGE
1. Knowledge of the basic science and normal physiol-
ogy of the immune response. Knowledge at this level
should include major mechanisms of host defense
(innate and adaptive); antigen presentation and sensi-
tization; the nature of humoral and cellular responses;
the roles of leukocytes, especially eosinophils, ba-
sophils, mast cells, dendritic cells, T cells, B cells,
stromal cells, mucosal epithelial cells, cytokines, and
chemokines. In particular, an understanding of Gell
and Coombs I–IV hypersensitivity reactions is essen-
tial as are an understanding of the late phase allergic
response [Ia] and some knowledge of inhalant, food,
drug, insect and latex allergens [Ib].
2. Knowledge of the global allergy epidemic, the epi-
demiology of allergic diseases and the likely gene-
environment interactions that affect prevalence [Ic].
3. Adequate clinical knowledge about the most com-
mon allergic diseases and the WAO classification of
allergic disease, including allergic rhinitis, allergic
conjunctivitis, rhinosinusitis, asthma, urticaria, hered-
itary and acquired angioedema, atopic eczema, aller-
gic contact dermatitis, food allergy, insect venom
allergy, anaphylaxis, drug allergy, occupational al-
lergy, and eosinophilic enteropathies [Ib].
4. Adequate understanding about comorbidities of al-
lergic diseases and the concept of the allergic
march, including the “reverse” atopic march [Ib].
5. Adequate theoretical knowledge of the mechanisms
underlying the interpretation of the basic diagnostic
allergy tests [IIb], patch tests, skin prick tests [IIb],
and serological tests [IIb] for total and specific IgE,
and an understanding of spirometry [IIb] and peak
flow measurement of lung function. Such training
need not include competency in performing skin
tests or pulmonary function tests, but in some coun-
tries training in anterior rhinoscopy or nasal endos-
copy could be offered [IIc].
6. Knowledge of evidence based therapeutic strategies
(indications, mechanism of action, efficacy, bene-
fits, side effects, and contraindications) for treat-
ing allergic diseases, such as antihistamines, oral
steroids, inhaled and intranasal steroids, and anti-IgE
[Ib]; limitations of injected steroids; leukotriene and
anti-IgE modifiers; theophylline; anticholinergics;
bronchodilators; cromones; adrenaline/epinephrine
[Ia]; allergen specific immunotherapy (sublingual
and/or subcutaneous specific allergen immunotherapy)
[Ib], and anti-IgE therapy. Knowledge of adverse med-
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ication reactions, and differentiating adverse from
allergic drug reactions, is clinically critical [Ic].
7. Adequate training to recognize the severity and
persistence of allergic diseases and the importance
of referral to an allergy specialist for evaluation and
initiation of treatment before the disease advances
to a severe or life-threatening stage. This will also
include referral for anti-IgE therapy and in some
countries would apply to the initiation of specific
allergen immunotherapy [Ic].
8. Knowledge of the concepts of primary and second-
ary immune responses, and response to vaccines
and infection [Ib].
9. Knowledge of the clinical manifestations of ana-
phylaxis, concepts of emergency treatment, and
knowledge of patient-initiated self-medication with
injectable epinephrine [Ia].
10. Understanding of the elements of primary and sec-
ondary prevention of allergic disease [Ic].
DIFFERENT FORMATS FOR TEACHING
ALLERGY TO MEDICAL STUDENTS
Allergy can be taught in a number of components of the
curriculum and can be included among the subjects taught in
Medicine, Pediatrics, Microbiology, and Immunology, or as a
component of organ-based specialty teaching, for example,
dermatology, ENT, internal medicine, and ophthalmology. If
allergy is taught as a component of different organ-based
specialties, a cohesive program should be developed to en-
sure that all major allergic disorders are covered. In some
countries such programs could be co-ordinated and be estab-
lished by Allergy departments.
Teaching allergy as part of systematic undergraduate
training and as problem solving around cases, are not mutu-
ally exclusive and can be combined. Each country can at-
tempt to include the essential topics into existing curricula in
different medical school training programs.
A. Systematic Undergraduate Education and
Training in Allergy
In this approach, students receive their teaching in two
phases:
Part I: Basic science
Y We assume that students have already undergone
education in the anatomy [Ia], physiology and
biochemistry relevant to the target organs of aller-
gic manifestations—lungs (eg, lung volumes, con-
trol of respiration, and adrenergic and histamine
receptors) [Ia], skin (eg, barrier function), nose,
eye, gut, and elements of statistics [Ic].
Y It is important that students are made aware of
the important indigenous allergens in their coun-
try and region and in different countries around
the world [Ic].
Two specific general lectures:
1. General overview (mast cells, basophils, T and B cells,
eosinophils, and so forth) [Ib].
2. Mechanism of organ-specific responses, for example,
Early/Late phase responses in skin, nose, eyes, lung,
and systemic allergic reactions [Ia].
ADDITIONAL TOPICS FOR CLINICAL SEMINARS
1. Trigger factors and risk factors: A general knowl-
edge of the common allergens [house dust mite,
pollens (grass, tree, weed), cat and dog allergens,
molds, insects/venoms, foods, drugs] and other trig-
gers of symptoms such as indoor and outdoor pol-
lutants. Knowledge about regional inhalant sensitiv-
ities. Knowledge about allergen avoidance and
environmental control measures [Ib].
2. Pharmacology: In addition to what is taught in gen-
eral pharmacology, additional information on the
anti-inflammatory roles of pharmacotherapeutic anti-
allergic agents, safety issues, and indications and
contraindications of antihistamines, steroids (inhaled,
nasal, and oral), leukotriene modifiers, bronchodilators,
anticholinergics, cromones and theophyllines [Ia], al-
lergen specific immunotherapy [Ib], and anti-IgE [Ic].
3. Immunology of the allergic response: Early and late
phase reactions [Ia], basic information on cells and
mediators involved in the allergic response, immu-
nologic basis for allergy tests, mechanisms of phar-
macotherapy, mechanisms of immunotherapy [Ib].
4. WAO classification of allergic disease [Ib].3
Part II: Clinical allergy training (with formal
lectures, clinical tutorials, ward rounds, case
studies, clinic attendance, clinico-pathology
conferences)
Three specific clinical allergy lectures:
1. IgE and anaphylaxis.
2. Importance of allergy in asthma, rhinitis, eczema and
occupational diseases, and their allergic comorbidities.
3. Treatment strategies emphasizing allergen avoidance, pa-
tient education, and immunotherapy in addition to phar-
macotherapy.
SUGGESTED TOPICS TO BE COVERED IN
CLINICAL LECTURES
1. A brief knowledge about the global allergy epidemic
and epidemiology of allergic diseases.
2. Clinical presentations of asthma, rhinitis, sinusitis,
allergic conjunctivitis, atopic eczema, urticaria, food
allergy, eosinophilic enteropathies, drug allergy, in-
sect/venom allergy, anaphylaxis, and occupational
allergies (eg, latex), using the WAO nomenclature
for allergy [Ib].3
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3. How in vivo and in vitro diagnostic tests are ordered
and interpreted: Skin prick tests, serum specific IgE
antibodies [Ib], patch tests [Ic], peak flow measure-
ments [Ia], and spirometry [Ib]. Instruction on the
precautions, techniques, indications, and limitations
of each test should be included.
4. Basic understanding of the value of skin prick tests
[Ia], patch tests [Ic], serum IgE specific antibody
tests [Ib], peak flow measurements [Ia] and spirom-
etry [Ib], and the quality of such tests and their
limitations [Ic]. Management plans including:
Y Allergen avoidance, knowing when it is necessary
Y Indications for pharmacotherapy with steroids,
antihistamines, antileukotrienes, bronchodilators, an-
ticholinergics, theophylline, adrenaline/epineph-
rine auto-injectors, allergen specific immuno-
therapy and anti-IgE [Ib]
Y Inhaler/spacer techniques [Ia]
Y Drug interactions and contraindications [Ic]
5. Resources for patients with allergies—self help groups,
Medic Alert and so forth [Ic].
6. Knowledge of what an Allergist can offer4 and when
to refer to a Specialist [Ic].
B. Problem Based Teaching/Problem Solving
Around Case Studies
At least 4 cases are recommended and study of on-line
cases such as those provided on the WAO Web site (www.
worldallergy.org). In this format, utilizing a case history with
multiple allergic manifestations as indicated in case 1 (be-
low), it is possible to teach the basic sciences of allergy (as
itemized in section B part 1) and clinical disease presentation,
and encourage correlation between the two, and also teach
pharmacotherapeutics. The combination of cases should
cover the common allergens, resources for patients, WAO
nomenclature for allergy,3 and epidemiology of allergic dis-
eases.
1. A child or an adult who has demonstrated the allergic
march from atopic eczema and food allergy to asthma and
allergic rhinitis with a strong family history of atopy.
2. Insect venom hypersensitivity to include mechanisms,
signs and symptoms, diagnosis, and action plans for man-
aging anaphylaxis, immunotherapy (theory and evidence
for efficacy and side effects), and other treatment options.
3. Latex/food allergy or pollen/oral allergy syndrome to
illustrate allergenic cross reactivity, avoidance strategies,
and pharmacotherapy.
4. Urticaria and angioedema; differential diagnosis, investi-
gations, and management.
5. A case study on anaphylaxis and emergency treatment (eg,
use of epinephrine).
6. A case study of acute, severe asthma with respiratory
distress that focuses on the differential diagnosis of an
asthma exacerbation and the interaction between infection
and allergy.
ASSESSMENT OF COMPETENCE IN ALLERGY
FOR MEDICAL STUDENTS
Assessment should be made by written and oral exam-
ination using either the “problem based approach” or the
“systematic teaching approach.” Recommended levels of
competence are marked in the syllabus.
1. Assessment of Part 1. Basic sciences such as pharmacol-
ogy, physiology, and immunology should be conducted by
written or multiple choice examination and could be
examined within the undergraduate Pathology/Pharmacol-
ogy Semester examinations.
2. Assessment of Part 2. Clinical allergy competence should
be conducted by written and oral examination:
a. Where a medical student is given an “allergy case” and
is asked to examine, diagnose, and then make a case
presentation, after which a series of clinical questions
are posed around the case (extended matching and/or
multiple choice).
b. Patients with allergies, for example, atopic eczema,
asthma, rhinitis, sinusitis, food allergy, insect/venom
allergy could also be included in the clinical cases for
the in-course and final evaluations of the students for
competence in Medicine and Pediatrics. Assessments
could be in the form of long cases or more reproducibly
by miniCex (mini-clinical evaluation exercise), OSCE
stations and/or PACEs (Practical Assessment of Clini-
cal Examination Skills).
Resources
It is important that textbooks suitable for undergrad-
uate training in allergy are made available to the medical
students, as well as electronic learning and on-line teach-
ing modules.
For example:
a. Roitt’s Essential Immunology. IM Roitt, PJ Delves, SJ
Martin, D Burton. Blackwell Publications, 2006.
b. Cellular and Molecular Immunology by Abbas and Lich-
tman, publisher Saunders, 6th edition 2007.
c. Allergy 3rd Edition, ST Holgate, MK Church, L Lichten-
stein ISBN: 13: 978 0 323 03227 8.
d. Allergies and their Management. RS Walls. MacLennan
and Petty, Sydney, Elsevier (Australia), 1997.
e. Lecture Notes in Immunology. WG Reeves, I Todd.
Blackwell Scientific Publications, 3rd edition, 2000.
f. A Color Atlas of Pediatric Allergy; JO Warner and WF
Jackson. Wolfe, 1994.
g. Prevention of Allergy and Allergic Asthma. World Allergy
Organization Project Report and Guidelines. Eds, S.G.O.
Johansson and T. Haahtela. In: Chemical Immunology and
Allergy, Vol. 84, 2004. Basel, Switzerland: Karger. Sum-
mary available at http://www.worldallergy.org/professional/
who_paa2003.pdf. Eds, J Ring et al.
h. WAO GLORIA Educational Modules (covering major
topics in allergy, eg, Asthma, Rhinitis, Eczema, Drug
Allergy, Anaphylaxis, Urticaria, Allergic Conjunctivitis,
Sinusitis and Nasal Polyposis.) Available at http://www.
worldallergy.org/educational_programs/gloria.
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i. The Allergic Diseases Resource Centre of the WAOWeb site–
www.worldallergy.org/adrc/ includes numerous educa-
tional synopses that provide suitable reading for students.
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APPENDIX
List of topics which medical students should be familiar
with to be competent in allergy when graduating as a medical
doctor.
1. ANATOMY [Ia]
Structure: Upper airway, lower airway, eyes, gastrointes-
tinal tract, skin.
2. PHYSIOLOGY [Ib]
Haemodynamics, blood pressure, lung function, lung vol-
umes, nasal physiology, gastro-intestinal function and cir-
culation, skin physiology and barrier function.
3. IMMUNOLOGY [Ib]
Immunology of the allergic response, mast cells, ba-
sophils, eosinophils, T Cells, regulatory T cells, IgE,
cytokines IL2, IL3, 4, 5, 10, TH1  TH2 pathways, TH17
cells, dendritic cells/antigen presenting cells. B cells,
plasma cells, immunoglobulin production, class switching,
cellular and humoral immune responses to proteins and
small chemical compounds (haptens) [Ib-Ic]. Regional
common inhalant allergens [Ib], common cross reactivities
(pollen/fruit etc) brief knowledge of regional aerobiology
[Ic], food allergens, occupational allergens (eg latex) [Ib],
mechanisms of immunotherapy. Markers of allergic in-
flammation (eosinophil cationic protein, eosinophils, nitric
oxide) [Ic].
4. DIAGNOSTICS
Mechanisms and interpretation of validated allergy skin
prick tests [Ia], mechanisms of specific serum IgE tests
[Ib]. Cut off values, predictive values. Total IgE values.
New developments in diagnostics. Interpretation of simple
lung function tests (PEFR and spirometry) [Ia] and normal
ranges, and rhinometry [Ic]. Allergen patch tests [Ic]. An
understanding that some tests have no scientific basis or
validation (eg IgG for food and other complementary
approaches, Vega testing) [Ic].
5. CLINICAL ENTITIES
Asthma [Ia], allergic rhinitis [Ia], nonallergic rhinitis [Ib],
acute and chronic sinusitis [Ib], atopic eczema [Ia], food
allergy [Ia], oral allergy syndrome [Ib], occupational
asthma, occupational allergies, urticaria and angioedema
[Ib], insect/venom allergy [Ib], allergic contact dermatitis
[Ib], drug allergies [Ib], co-morbid diseases of allergy
(sinusitis, otitis). Differential diagnosis of allergies (eg
mastocytosis, allergic alveolitis) [Ic]. Hereditary and ac-
quired C1 esterase inhibitor deficiency [Ic]. Knowledge
about availability of management guidelines, where to find
them, and key points for general practitioners. Global
Initiative for Asthma (GINA) [Ic] and Allergic Rhinitis
and its Impact on Asthma (ARIA) [Ic] (or national)
guidelines. The evidence base for non-pharmacological
treatment (eg, house dust mite avoidance).
6. PHARMACOTHERAPEUTICS
Antihistamines (first and second generation; oral and in-
tranasal) [Ia]
Glucocorticosteroids (topical and oral) [Ia]





Immunotherapy: Subcutaneous and Sublingual [Ib]
Pharmacoeconomics [Ic]
Drug interactions [Ic]
Adverse effects of chronic medication [Ic]
Monitoring growth in children and adverse events in all
patients on steroids [Ia]
The role of specialized interventions, eg anti-IgE ther-
apy [Ic]
Future potential for cytokine management of allergic
diseases [Ic]
Emerging concepts of pharmacogenetics [Ic]
Calcineurin inhibitors [Ic]
7. LINES OF COMMUNICATION
When to refer to a specialist [Ib]
How to use WAO and other resources in Allergy (on-
line) [Ic]
Patient resources/support groups (on-line) [Ic]
Resources of the National Allergy Societies in the
region [Ic]
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